Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 450

1.

Deregulation of the Histone Lysine-Specific Demethylase 1 Is Involved in Human Hepatocellular Carcinoma.

Kim S, Bolatkan A, Kaneko S, Ikawa N, Asada K, Komatsu M, Hayami S, Ojima H, Abe N, Yamaue H, Hamamoto R.

Biomolecules. 2019 Dec 1;9(12). pii: E810. doi: 10.3390/biom9120810.

PMID:
31805626
2.

A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.

Abe K, Shang J, Shi X, Yamashita T, Hishikawa N, Takemoto M, Morihara R, Nakano Y, Ohta Y, Deguchi K, Ikeda M, Ikeda Y, Okamoto K, Shoji M, Takatama M, Kojo M, Kuroda T, Ono K, Kimura N, Matsubara E, Osakada Y, Wakutani Y, Takao Y, Higashi Y, Asada K, Senga T, Lee LJ, Tanaka K.

J Alzheimers Dis. 2019 Nov 18. doi: 10.3233/JAD-191016. [Epub ahead of print]

PMID:
31771070
3.

Filifactor alocis brain abscess identified by 16S ribosomal RNA gene sequencing: A case report.

Hishiya N, Uno K, Amano M, Asada K, Masui K, Ishida Y, Suzuki Y, Hirai N, Nakano A, Nakano R, Kasahara K, Yano H, Mikasa K.

J Infect Chemother. 2019 Nov 8. pii: S1341-321X(19)30292-2. doi: 10.1016/j.jiac.2019.09.013. [Epub ahead of print]

PMID:
31711830
4.

Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD.

Suzuki Y, Inui N, Karayama M, Imokawa S, Yamada T, Yokomura K, Asada K, Kusagaya H, Kaida Y, Matsuda H, Koshimizu N, Toyoshima M, Masuda M, Hayakawa H, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Suda T.

Int J Chron Obstruct Pulmon Dis. 2019 Aug 21;14:1867-1877. doi: 10.2147/COPD.S214610. eCollection 2019.

5.

[Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].

Yamamoto M, Ide N, Kitajima S, Obayashi M, Asada K, Matsushima S, Ito M.

Yakugaku Zasshi. 2019;139(11):1479-1483. doi: 10.1248/yakushi.19-00120. Japanese.

6.

Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study.

Tanaka Y, Matsubara O, Asada K, Muramatsu A, Suzuki M, Shirai T.

Respir Med Case Rep. 2019 Jun 13;28:100885. doi: 10.1016/j.rmcr.2019.100885. eCollection 2019.

7.

Combined effect of a farnesoid X receptor agonist and dipeptidyl peptidase-4 inhibitor on hepatic fibrosis.

Shimozato N, Namisaki T, Kaji K, Kitade M, Okura Y, Sato S, Moriya K, Seki K, Kawaratani H, Takaya H, Sawada Y, Saikawa S, Nakanishi K, Furukawa M, Fujinaga Y, Kubo T, Asada K, Kitagawa K, Tsuji Y, Kaya D, Ozutsumi T, Akahane T, Mitoro A, Yoshiji H.

Hepatol Res. 2019 Oct;49(10):1147-1161. doi: 10.1111/hepr.13385. Epub 2019 Jul 15.

PMID:
31177586
8.

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.

Kojima M, Sone K, Oda K, Hamamoto R, Kaneko S, Oki S, Kukita A, Machino H, Honjoh H, Kawata Y, Kashiyama T, Asada K, Tanikawa M, Mori-Uchino M, Tsuruga T, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Osuga Y, Fujii T.

BMC Cancer. 2019 May 15;19(1):455. doi: 10.1186/s12885-019-5638-9.

9.

Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting.

Tanaka K, Inui N, Karayama M, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kusagaya H, Matsuura S, Uto T, Hashimoto D, Matsui T, Asada K, Suda T.

Cancer Chemother Pharmacol. 2019 Jul;84(1):147-153. doi: 10.1007/s00280-019-03868-5. Epub 2019 May 13.

PMID:
31087137
10.

Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis.

Tanaka Y, Shirai T, Asada K, Muramatsu A, Katsumata M, Suda T.

Clin Case Rep. 2019 Mar 2;7(4):731-734. doi: 10.1002/ccr3.2068. eCollection 2019 Apr.

11.

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.

Kukita A, Sone K, Oda K, Hamamoto R, Kaneko S, Komatsu M, Wada M, Honjoh H, Kawata Y, Kojima M, Oki S, Sato M, Asada K, Taguchi A, Miyasaka A, Tanikawa M, Nagasaka K, Matsumoto Y, Wada-Hiraike O, Osuga Y, Fujii T.

Biochem Biophys Res Commun. 2019 May 28;513(2):340-346. doi: 10.1016/j.bbrc.2019.03.155. Epub 2019 Apr 4.

PMID:
30955858
12.

Characterization of an Unusual DS-1-Like G8P[8] Rotavirus Strain from Japan in 2017: Evolution of Emerging DS-1-Like G8P[8] Strains through Reassortment.

Kamiya H, Tacharoenmuang R, Ide T, Negoro M, Tanaka T, Asada K, Nakamura H, Sugiura K, Umemoto M, Kuroki H, Ito H, Tanaka S, Ito M, Fukuda S, Hatazawa R, Hara Y, Guntapong R, Murata T, Taniguchi K, Suga S, Nakano T, Taniguchi K, Komoto S.

Jpn J Infect Dis. 2019 Jul 24;72(4):256-260. doi: 10.7883/yoken.JJID.2018.484. Epub 2019 Feb 28.

13.

Effects of hot water extract of Curcuma longa on human epidermal keratinocytes in vitro and skin conditions in healthy participants: A randomized, double-blind, placebo-controlled trial.

Asada K, Ohara T, Muroyama K, Yamamoto Y, Murosaki S.

J Cosmet Dermatol. 2019 Dec;18(6):1866-1874. doi: 10.1111/jocd.12890. Epub 2019 Feb 27.

PMID:
30809971
14.

Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.

Akiyama N, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Uto T, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Suda T.

Invest New Drugs. 2019 Jun;37(3):531-537. doi: 10.1007/s10637-019-00747-x. Epub 2019 Feb 21.

PMID:
30790149
15.

Improved cough- and sputum-related quality of life after initiation of treatment in pulmonary tuberculosis.

Suzuki T, Shirai T, Hirai K, Tanaka Y, Watanabe H, Endo Y, Shimoda Y, Saigusa M, Akamatsu T, Yamamoto A, Morita S, Asada K.

Respir Investig. 2019 May;57(3):252-259. doi: 10.1016/j.resinv.2019.01.002. Epub 2019 Feb 6.

PMID:
30738923
16.

Efficacy and Safety of Amrubicin in Non-Small-Cell Lung Cancer Patients Beyond Third-Line Therapy.

Saigusa M, Asada K, Akamatsu T, Tanaka Y, Endo Y, Yamamoto A, Morita S, Shirai T.

Oncol Res Treat. 2019;42(1-2):52-56. doi: 10.1159/000493199. Epub 2018 Dec 12.

PMID:
30537755
17.

Forced oscillatory parameters in reversibility testing as predictors for chronic cough responsive to inhaled corticosteroid/long-acting β2 agonist.

Watanabe H, Shirai T, Akamatsu T, Asada K, Hirai K.

Ann Allergy Asthma Immunol. 2019 Mar;122(3):345-346.e1. doi: 10.1016/j.anai.2018.10.008. Epub 2018 Oct 17. No abstract available.

PMID:
30342091
18.

Metastatic pulmonary malignant melanoma showing a ring-shaped and halo signs.

Masuda T, Shirai T, Saigusa M, Asada K, Muro H.

Respirol Case Rep. 2018 Sep 23;6(8):e00370. doi: 10.1002/rcr2.370. eCollection 2018 Nov.

19.

Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis.

Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shirai T, Hayakawa H, Suda T.

Sci Rep. 2018 Sep 3;8(1):13129. doi: 10.1038/s41598-018-31565-5.

20.

A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.

Suga S, Ishiwada N, Sasaki Y, Akeda H, Nishi J, Okada K, Fujieda M, Oda M, Asada K, Nakano T, Saitoh A, Hosoya M, Togashi T, Matsuoka M, Kimura K, Shibayama K.

Vaccine. 2018 Sep 11;36(38):5678-5684. doi: 10.1016/j.vaccine.2018.08.029. Epub 2018 Aug 16.

PMID:
30122645
21.

Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model.

Seki K, Kitade M, Nishimura N, Kaji K, Asada K, Namisaki T, Moriya K, Kawaratani H, Okura Y, Takaya H, Sawada Y, Sato S, Nakanishi K, Yoshiji H.

Oncotarget. 2018 Jun 19;9(47):28638-28651. doi: 10.18632/oncotarget.25587. eCollection 2018 Jun 19.

22.

Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study.

Nishimoto K, Karayama M, Inui N, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inami N, Matsuura S, Kaida Y, Matsui T, Asada K, Matsuda H, Fujii M, Toyoshima M, Imokawa S, Suda T.

Med Oncol. 2018 Jun 16;35(7):108. doi: 10.1007/s12032-018-1172-x.

PMID:
29909581
23.

Cytosolic Genomic DNA functions as a Natural Antisense.

Asada K, Ito K, Yui D, Tagaya H, Yokota T.

Sci Rep. 2018 Jun 4;8(1):8551. doi: 10.1038/s41598-018-26487-1.

24.

Angubindin-1 opens the blood-brain barrier in vivo for delivery of antisense oligonucleotide to the central nervous system.

Zeniya S, Kuwahara H, Daizo K, Watari A, Kondoh M, Yoshida-Tanaka K, Kaburagi H, Asada K, Nagata T, Nagahama M, Yagi K, Yokota T.

J Control Release. 2018 Aug 10;283:126-134. doi: 10.1016/j.jconrel.2018.05.010. Epub 2018 May 17.

25.

Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP®-MS analysis.

Uchiyama K, Naito Y, Yagi N, Mizushima K, Higashimura Y, Hirai Y, Dohi O, Okayama T, Yoshida N, Katada K, Kamada K, Handa O, Ishikawa T, Takagi T, Konishi H, Nonaka D, Asada K, Lee LJ, Tanaka K, Kuriu Y, Nakanishi M, Otsuji E, Itoh Y.

J Gastroenterol. 2018 Nov;53(11):1179-1185. doi: 10.1007/s00535-018-1448-0. Epub 2018 Mar 1.

PMID:
29497816
26.

Surgical resection for clinical stage I high-grade neuroendocrine carcinoma of the lung.

Mochizuki E, Matsuura S, Oishi K, Miyashita K, Ichijyo K, Furukawa S, Nagaoka M, Mikura S, Tsukui M, Koshimizu N, Sakurai S, Asada K, Shirai T.

World J Surg Oncol. 2018 Feb 17;16(1):33. doi: 10.1186/s12957-018-1337-2.

27.

Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosis.

Namisaki T, Moriya K, Kitade M, Takeda K, Kaji K, Okura Y, Shimozato N, Sato S, Nishimura N, Seki K, Kawaratani H, Takaya H, Sawada Y, Akahane T, Saikawa S, Nakanishi K, Kubo T, Furukawa M, Noguchi R, Asada K, Kitagawa K, Ozutsumi T, Tsuji Y, Kaya D, Fujinaga Y, Yoshiji H.

Hepatol Commun. 2017 Sep 19;1(9):928-945. doi: 10.1002/hep4.1104. eCollection 2017 Nov.

28.

Characterization of unusual DS-1-like G3P[8] rotavirus strains in children with diarrhea in Japan.

Komoto S, Ide T, Negoro M, Tanaka T, Asada K, Umemoto M, Kuroki H, Ito H, Tanaka S, Ito M, Fukuda S, Suga S, Kamiya H, Nakano T, Taniguchi K.

J Med Virol. 2018 May;90(5):890-898. doi: 10.1002/jmv.25016. Epub 2018 Feb 5.

PMID:
29315643
29.

Lesion characteristics and procedural outcomes of re-attempted percutaneous coronary interventions for chronic total occlusion.

Tanabe M, Kodama K, Asada K, Kunitomo T.

Heart Vessels. 2018 Jun;33(6):573-582. doi: 10.1007/s00380-017-1091-3. Epub 2017 Dec 9.

PMID:
29224054
30.

Publisher Correction: Autonomic versus perceptual accounts for tactile hypersensitivity in autism spectrum disorder.

Fukuyama H, Kumagaya SI, Asada K, Ayaya S, Kato M.

Sci Rep. 2017 Dec 5;7(1):17276. doi: 10.1038/s41598-017-17125-3.

31.

Brief Report: Body Image in Autism: Evidence from Body Size Estimation.

Asada K, Tojo Y, Hakarino K, Saito A, Hasegawa T, Kumagaya S.

J Autism Dev Disord. 2018 Feb;48(2):611-618. doi: 10.1007/s10803-017-3323-x.

PMID:
29038931
32.

Comparison of fractional exhaled nitric oxide levels measured using the NIOX VERO and NOA 280i.

Endo Y, Shirai T, Akamatsu T, Asada K.

Ann Allergy Asthma Immunol. 2017 Oct;119(4):383-385. doi: 10.1016/j.anai.2017.07.026. No abstract available.

PMID:
28958377
33.

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.

Matsushita H, Hasegawa K, Oda K, Yamamoto S, Nishijima A, Imai Y, Asada K, Ikeda Y, Karasaki T, Fujiwara K, Aburatani H, Kakimi K.

Oncoimmunology. 2017 Jun 16;6(8):e1338996. doi: 10.1080/2162402X.2017.1338996. eCollection 2017.

34.

Autonomic versus perceptual accounts for tactile hypersensitivity in autism spectrum disorder.

Fukuyama H, Kumagaya SI, Asada K, Ayaya S, Kato M.

Sci Rep. 2017 Aug 15;7(1):8259. doi: 10.1038/s41598-017-08730-3. Erratum in: Sci Rep. 2017 Dec 5;7(1):17276.

35.

Correlation between the proportion of stained eggs and the number of mites (Dermanyssus gallinae) monitored using a 'non-parallel board trap'.

Odaka M, Ogino K, Shikada M, Asada K, Kasa S, Inoue T, Maeda K.

Anim Sci J. 2017 Dec;88(12):2077-2083. doi: 10.1111/asj.12860. Epub 2017 Jul 18.

PMID:
28719068
36.

A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.

Hirai K, Shirai T, Suzuki M, Akamatsu T, Suzuki T, Hayashi I, Yamamoto A, Akita T, Morita S, Asada K, Tsuji D, Inoue K, Itoh K.

Clin Exp Allergy. 2017 Nov;47(11):1374-1382. doi: 10.1111/cea.12970. Epub 2017 Aug 1.

PMID:
28658564
37.

Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.

Kako Y, Yamakado K, Jomoto W, Nasada T, Asada K, Takaki H, Kobayashi K, Daimon T, Hirota S.

Jpn J Radiol. 2017 Jul;35(7):366-372. doi: 10.1007/s11604-017-0647-6. Epub 2017 May 13.

PMID:
28501975
38.

Long-term change in reactance by forced oscillation technique correlates with FEV1 decline in moderate COPD patients.

Akita T, Shirai T, Akamatsu T, Saigusa M, Yamamoto A, Shishido Y, Morita S, Asada K.

Eur Respir J. 2017 Apr 26;49(4). pii: 1601534. doi: 10.1183/13993003.01534-2016. Print 2017 Apr. No abstract available.

39.

Production of Homogeneous Cultured Human Corneal Endothelial Cells Indispensable for Innovative Cell Therapy.

Toda M, Ueno M, Hiraga A, Asada K, Montoya M, Sotozono C, Kinoshita S, Hamuro J.

Invest Ophthalmol Vis Sci. 2017 Apr 1;58(4):2011-2020. doi: 10.1167/iovs.16-20703.

PMID:
28384722
40.

Changes in Rotavirus Genotypes before and after Vaccine Introduction: a Multicenter, Prospective Observational Study in Three Areas of Japan.

Tanaka T, Kamiya H, Asada K, Suga S, Ido M, Umemoto M, Ouchi K, Ito H, Kuroki H, Nakano T, Taniguchi K.

Jpn J Infect Dis. 2017 Jul 24;70(4):448-452. doi: 10.7883/yoken.JJID.2016.286. Epub 2017 Feb 28.

41.

Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan.

Asada K, Kamiya H, Suga S, Nagao M, Ichimi R, Fujisawa T, Umemoto M, Tanaka T, Ito H, Tanaka S, Ido M, Taniguchi K, Ihara T, Nakano T.

Western Pac Surveill Response J. 2016 Nov 14;7(4):28-36. doi: 10.5365/WPSAR.2016.7.3.005. eCollection 2016 Oct-Dec.

42.

Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis.

Okura Y, Namisaki T, Moriya K, Kitade M, Takeda K, Kaji K, Noguchi R, Nishimura N, Seki K, Kawaratani H, Takaya H, Sato S, Sawada Y, Shimozato N, Furukawa M, Nakanishi K, Saikawa S, Kubo T, Asada K, Yoshiji H.

Hepatol Res. 2017 Nov;47(12):1317-1328. doi: 10.1111/hepr.12860. Epub 2017 Feb 13.

PMID:
28029729
43.

High impact of methylation accumulation on metachronous gastric cancer: 5-year follow-up of a multicentre prospective cohort study.

Maeda M, Nakajima T, Oda I, Shimazu T, Yamamichi N, Maekita T, Asada K, Yokoi C, Ando T, Yoshida T, Nanjo S, Fujishiro M, Gotoda T, Ichinose M, Ushijima T.

Gut. 2017 Sep;66(9):1721-1723. doi: 10.1136/gutjnl-2016-313387. Epub 2016 Dec 21. No abstract available.

44.

Forced oscillation technique as a predictor of FEV1 improvement in asthma.

Akamatsu T, Shirai T, Shimoda Y, Suzuki T, Hayashi I, Noguchi R, Mochizuki E, Sakurai S, Saigusa M, Yamamoto A, Shishido Y, Akita T, Morita S, Asada K.

Respir Physiol Neurobiol. 2017 Feb;236:78-83. doi: 10.1016/j.resp.2016.11.013. Epub 2016 Nov 21.

PMID:
27884795
45.

MicroRNA Profiles Qualify Phenotypic Features of Cultured Human Corneal Endothelial Cells.

Ueno M, Asada K, Toda M, Hiraga A, Montoya M, Sotozono C, Kinoshita S, Hamuro J.

Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5509-5517. doi: 10.1167/iovs.16-19804.

PMID:
27768788
46.

Metabolic Plasticity in Cell State Homeostasis and Differentiation of Cultured Human Corneal Endothelial Cells.

Hamuro J, Ueno M, Asada K, Toda M, Montoya M, Sotozono C, Kinoshita S.

Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4452-4463. doi: 10.1167/iovs.16-19807.

PMID:
27750287
47.

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

Makii C, Oda K, Ikeda Y, Sone K, Hasegawa K, Uehara Y, Nishijima A, Asada K, Koso T, Fukuda T, Inaba K, Oki S, Machino H, Kojima M, Kashiyama T, Mori-Uchino M, Arimoto T, Wada-Hiraike O, Kawana K, Yano T, Fujiwara K, Aburatani H, Osuga Y, Fujii T.

Oncotarget. 2016 Nov 15;7(46):75328-75338. doi: 10.18632/oncotarget.12175.

48.

DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis.

Asada K, Aihara Y, Takaya H, Noguchi R, Namisaki T, Moriya K, Uejima M, Kitade M, Mashitani T, Takeda K, Kawaratani H, Okura Y, Kaji K, Douhara A, Sawada Y, Nishimura N, Seki K, Mitoro A, Yamao J, Yoshiji H.

World J Hepatol. 2016 Oct 8;8(28):1194-1199.

49.

Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.

Suzuki Y, Shirai M, Asada K, Miwa S, Karayama M, Nakamura Y, Inui N, Shirai T, Hayakawa H, Baba S, Suda T.

Ann Am Thorac Soc. 2017 Jan;14(1):57-64. doi: 10.1513/AnnalsATS.201607-528OC.

PMID:
27684274
50.

A druggable target for rescuing microRNA defects.

Asada K, Canestrari E, Paroo Z.

Bioorg Med Chem Lett. 2016 Oct 15;26(20):4942-4946. doi: 10.1016/j.bmcl.2016.09.019. Epub 2016 Sep 13.

PMID:
27641467

Supplemental Content

Support Center